## **Core Concept**
Seronegative spondyloarthropathies (SpA) are a group of rheumatic diseases characterized by the absence of rheumatoid factor (seronegative) and inflammation of the spine and sacroiliac joints. The primary treatment goals are to reduce inflammation, alleviate symptoms, and prevent long-term joint damage.

## **Why the Correct Answer is Right**
The correct answer, **Nonsteroidal Anti-Inflammatory Drugs (NSAIDs)**, are considered the first-line treatment for seronegative spondyloarthropathies, particularly for conditions like ankylosing spondylitis, psoriatic arthritis, reactive arthritis, and enteropathic arthritis associated with inflammatory bowel disease. NSAIDs effectively reduce inflammation and alleviate pain and stiffness.

## **Why Each Wrong Option is Incorrect**
- **Option A:** While **Disease-Modifying Antirheumatic Drugs (DMARDs)**, such as sulfasalazine and methotrexate, can be used in the treatment of seronegative spondyloarthropathies, especially in patients who do not respond to NSAIDs or have peripheral arthritis, they are not the initial treatment of choice for axial symptoms.
- **Option B:** **Biologic agents**, including tumor necrosis factor-alpha (TNF-alpha) inhibitors, are considered for patients who have not responded adequately to NSAIDs and conventional DMARDs. They are effective but usually reserved for patients with more severe disease or inadequate response to first-line treatments due to their cost and potential side effects.
- **Option D:** **Corticosteroids** can be used in the management of acute flares of seronegative spondyloarthropathies but are not the preferred long-term treatment due to their side effects.

## **Clinical Pearl / High-Yield Fact**
A key point to remember is that the treatment of seronegative spondyloarthropathies often involves a combination of therapeutic modalities, including physical therapy to maintain spinal mobility. Among pharmacological treatments, NSAIDs are generally the first line for managing axial symptoms, while DMARDs and biologics may be added for peripheral arthritis or in cases of inadequate response.

## **Correct Answer:** . **Nonsteroidal Anti-Inflammatory Drugs (NSAIDs)**